Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Mitigation of the ongoing coronavirus disease 2019 (COVID-19) pandemic requires reliable and accessible laboratory diagnostic services. In this study, the performance of one laboratory-developed test (LDT) and two commercial tests, cobas SARS-CoV-2 (Roche) and Amplidiag COVID-19 (Mobidiag), were eva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mol Diagn
Main Authors: Mannonen, Laura, Kallio-Kokko, Hannimari, Loginov, Raisa, Jääskeläinen, Anu, Jokela, Pia, Antikainen, Jenni, Väre, Paula, Kekäläinen, Eliisa, Kurkela, Satu, Jarva, Hanna, Lappalainen, Maija
Formato: Artigo
Idioma:Inglês
Publicado em: Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. 2021
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7825913/
https://ncbi.nlm.nih.gov/pubmed/33486074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2021.01.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados